Physician profile
Christopher S Connell
NPI 1215388798
$2,023.16
in general payments reported to CMS, 2019-2025
15 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.36 · 2021: $934 · 2022: $40.00 · 2023: $191 · 2024: $518 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.17 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $970.71 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $192.73 | 2024-2025 | Acthar |
| Bausch & Lomb Americas INC. | $183.57 | 2023-2025 | Xiidra, Miebo, Ic-8 Apthera Iol |
| Oyster Point Pharma, INC. | $117.74 | 2022-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $98.59 | 2023-2025 | Lumigan, Alphagan P |
| Tarsus Pharmaceuticals, INC. | $90.05 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $71.26 | 2025 | Vevye |
| Alcon Vision LLC | $65.28 | 2024-2025 | Rocklatan |
| Amgen INC. | $45.19 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $42.00 | 2024 | |
| Sun Pharmaceutical Industries INC. | $35.95 | 2023-2025 | Cequa |
| Thea Pharma INC. | $29.42 | 2024 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $28.52 | 2023 | |
| Beaver-Visitec International, INC. | $27.95 | 2023 | |
| Horizon Therapeutics Plc | $24.20 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Connell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.